Center for Connected Medicine’s Post

Just over a year ago, Imran Mahmud, MD introduced to me what was then called, Co:Helm. I was taken by the backgrounds and stories of Abdel Mahmoud, MD, Zahid Mahmood & Tahseen Omar and moreso their grit and determination to forge ahead with their mission of reducing the cost of healthcare. They soon got into the Sequoia Arc program with the backing of another friend, George Robson. And have been staying low and building ever since. Inbetween rebrandng to Anterior (formerly Co:Helm). And even more recently announced a new round to add more fuel. https://lnkd.in/e3V4qrRz Happy to be a supporter alongside Annelie Ajami, Dorothy Chou, Adil Mohammed, Andy Young, Caroline Mogford, Christian Arno, Felix Leuschner, Freddy Kelly, Leonard Picardo, Mandeep Singh, Michael Steel, Omid Ashtari, Noor Shaker, Sultan Murad Saidov, Yuelin Li and others in the ecosystem... [Anterior is giving clinicians a second set of hands—and fixing one of the biggest pain points for patients. It is a LLM-powered co-pilot for administration, handling all the work that comes before the clinical decision-making. Where it might take a nurse several hours to track down, organize and summarize hundreds of pages of records they need, Anterior can do it in seconds, allowing clinicians to increase their output tenfold and focus on what matters most: helping patients.] #healthcare

🔍 What happened in Digital Health during Q1 2024  🏥 👇VC Insights shared by PitchBook: 📊 Funding Overview: - $1.1 billion raised across 77 deals, consistent with recent quarters. - Top deals: Transcarent ($126.0M) and Rightway ($108.8M). 👥 Investor Activity: - Alumni Ventures was the most active digital health VC investor with 4 deals, followed by Connecticut Innovations with 3. 🔄 Market Dynamics: - Minimal VC exits; notable exception: Twill acquired by DarioHealth . - Expectations of increased consolidation in digital health. 📈 IPO Landscape: - Limited activity; Waystar went public at a $3.5B valuation, and Tempus AI raised $410.7M in the IPO at an implied valuation of $6.1B. 🔮 Future Outlook: - Continued consolidation driven by reimbursement challenges and therapeutic advancements. 🔗 For more detailed insights, check out the full PitchBook Q1 2024 report in the comments. SISTAFUND is always on the lookout for disruptive digital health startups: if you are in this space, feel free to reach out! 🌟 #DigitalHealth #VentureCapital #HealthcareInnovation

Last few spaces remaining for this masterclass with Trung Nghia Ton of Foundry Health so apply now to secure your spot ➡️ https://lnkd.in/eVX55QWk Trung is an experienced clinician, ex-McKinsey strategy consultant and healthcare startup founder with experience building health tech ventures for many markets. In this masterclass, Trung will share his knowledge on: 🎯 Practicalities and strategies for raising funding in the healthcare industry 🎯 What to expect from investors in 2024? 🎯 Will mergers and acquisitions become a natural path for many startups? #venturecapital #digitalhealth #globalhealth

💻 Check out our latest blog post on the IPO watchlist for Digital Health to stay informed on the evolving landscape! 🏥 #DigitalHealth #IPO #HealthTech 📈 Despite a recent slowdown in late-stage funding, experts predict a positive outlook with at least three successful IPOs expected in 2024. 📉 🔬 Technological advancements are driving rapid growth in the digital health sector, with companies like 23andMe, Roivant Sciences, and Butterfly Network leading the way. 👩🏽💻 How can NextRound.ai help founders in fundraising? 📍 NextRound.ai provides a personalized approach and innovative platform to empower founders with AI-driven insights and analytics, increasing their chances of securing investments and achieving successful IPOs. 💰 For more information and insights, visit our blog post here: https://nextround.ai/blog/. #NextRound #Fundraising #SuccessStories ✅🌤️

𝗪𝗵𝗼 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗺𝗼𝘀𝘁 𝗮𝗰𝘁𝗶𝘃𝗲 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀 𝗳𝗼𝗿 𝘀𝗲𝗲𝗱 𝗮𝗻𝗱 𝘀𝗲𝗿𝗶𝗲𝘀 𝗔 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵 𝘁𝗲𝗰𝗵 𝗶𝗻 𝗕𝗲𝗹𝗴𝗶𝘂𝗺?💡 Dive into the full list of the most active VC investors in Belgian health tech and uncover valuable perspectives on their areas of interest and the range of projects they support 👇🏼 #HealthTechInnovations #HealthTech #FutureOfHealthcare #VentureCapital #Investors

Our team is proud to share that Fabric has raised $60 million in Series A funding! Thanks to General Catalyst and continued support from Thrive Capital, GV (Google Ventures), Salesforce Ventures, Vast Ventures, BoxGroup, and Atento Capital. Fabric streamlines virtual and in-person care with an intelligent care enablement system that powers healthcare to move faster, work smarter, and deliver better care. Thanks to this new round of funding, we're positioned to further grow our team and our solutions, which have already proven to create more capacity to care by: - Increasing provider efficiency 2-10x depending on the setting - Decreasing call center wait times by 35% - Reducing rooming to discharge times by 20% If you’re passionate about solving healthcare’s capacity problem, let’s connect! Aniq Rahman Aiden Feng, MD, MBA Stefan Behrens Lisa (Ragen) Ide, MD, MPH Anders Carlson, MD Kimberly Ericson Rosacker Matt Booker Hodges Corey VanSpronsen Jonathan Porter Jonathan Pearce Read more: https://hubs.ly/Q02lNj4V0

Are you working on an idea and building it to IPO? Here's a guide that may help you gain some insights to how to do it.

We released our H1 2024 funding analysis a couple of days ago, and there's plenty to sift through. Have a look! https://lnkd.in/gVB4hEiq There's a fair bit we didn't get to, however. Here's a few market data points that summarize the moment we're in: 1. It's 2018 again Deal volume and average deal size are the same as six years ago. Notably, Rock Health ended 2018 and 2019 with predictions of a market pullback... that seemingly never arrived. 2. Extension rounds are (still) in vogue In Q2 2024, fully 1/3 of all deals appear to be extension rounds - down from 55% of all deals in Q4 2023. To put this in perspective, for the whole of 2019 _just 4% of all deals_ met the criteria to be counted as "extensions" in our data set. (Yes. You read that right.) 3. Around 1/4 of extension rounds *appear* to be extensions of extensions Caveat: This is tricky to track precisely (because deal terms are not generally made public). Methodologically, "extension of extension" is inferred in cases where we tracked SEC data that shows a company raising two rounds in a row that have no designated round label (e.g., "Series Seed" or "Series F"). With that caveat out of the way, it's significant to note that "extensions of extensions" wasn't really a thing in 2023 (because extensions in 2023 mostly followed Seed or Series A rounds). By extension (ahem), I predict that capital market appetite for extensions will begin to run dry by the end of 2024 (which has implications for VC funding in 2025). 4. VCs aren't raising much money from LPs right now - and big generalist funds are raising the bulk of it. Per Pitchbook, just two funds (a16z and GC) raised almost half (44%) of all VC dollars so far in 2024 - twice the proportion "large funds" typically attract. Specialist funds (like Rock Health Capital) are perhaps that much more "special." 😅 And we're likewise incredibly fortunate to have closed our most recent fund in Q3 last year.

#FoundationHealth's Seed Funding: A Leap Towards Digital-First Healthcare Solutions Foundation Health has successfully closed a $6 million seed funding round. This investment propels the company into a new era of growth, with the backing of industry heavyweights like Garry Tan and an array of venture capital firms and angel investors including Transpose Platform, Alt Capital, Exceptional Capital among others. Foundation Health's mission is clear: to revolutionize consumer healthcare by enabling swift development and launch of digital-first pharmacy and telehealth solutions. Their vision? To become the go-to tech platform for managing complex healthcare operations worldwide. The company's strategic focus is on three B2B products: 1. APIs for Telehealth Prescribing and Pharmacy Services 2. Virtual Pharmacy SaaS Product 3. Virtual Direct-to-Patient Service Each offering is designed to address critical needs within the healthcare landscape, from connecting clients to telehealth providers to enabling pharmaceutical manufacturers to directly reach patients. 📈 Market Implications: Foundation Health's innovative approach is a response to the demand for affordable, tech-enabled healthcare solutions. Their commitment to speed, scale, and affordability positions them as a disruptive force in the healthcare technology sector, especially within the US market. Investment Opportunities: 💡 Healthcare Technology Innovation: Investing in companies like Foundation Health, which are at the forefront of digital healthcare solutions, presents substantial potential. 💡 Disruptive Market Entry: The company's speed-to-market and cost-effective services offer compelling investment prospects for those seeking disruptive strategies. 💡 Global Expansion Potential: Foundation Health's potential for international growth opens avenues for investors to capitalize on its global trajectory. As Foundation Health gears up for profitability within the next 18 months, it stands as a testament to the transformative power of health tech innovation. For investors and business leaders, this marks a pivotal moment to consider the strategic significance and market impact of such trailblazing ventures. For more insights into the dynamic world of consumer healthcare technology, follow Market Unwinded - Your compass for navigating market transformations. Read More: https://lnkd.in/gwkiCyFh #HealthTech #DigitalHealthcare #Telehealth #PharmacySolutions #SeedFunding #MarketUnwinded #StrategicGrowth #InvestmentOpportunities

The Q1 2024 data is cooling, and the FY2023 numbers are out. Together, they tell a story about a moderating Healthcare Tech sector. Deals are happening, but slowly, with less capital, and with greater scrutiny on objective measures of startup performance.  In the May BIP Ventures Healthcare Tech Newsletter, we track the signs of a digital healthcare sector reset, including where M&A deals are happening. You'll also find out which of the BIP Ventures portfolio companies were named to the Newsweek and Statista World's Best Digital Healthcare Companies 2024 list. Get a copy and subscribe 🏥 https://buff.ly/3qLTDXv #Healthcare #HealthcareTech #M&A #Funding #Investment #Innovation #VentureCapital #Trends